AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2012
Aug 20, 2012
30826_dirs_2012-08-20_11df810e-6661-45f7-9ee3-186d625a7fe8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-08-16
Reporting Person: GRIFFITH MICHAEL A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-16 | Common Stock | P | 1600 | $4.880 | Acquired | 1600 | Direct |
| 2012-08-16 | Common Stock | P | 200 | $4.879 | Acquired | 1800 | Direct |
| 2012-08-16 | Common Stock | P | 200 | $4.868 | Acquired | 2000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.53 | 2022-05-24 | Common Stock (24000) | 24000 | Direct |
Footnotes
F1: 8,000 shares vest and become exercisable on each of the following dates: 5/24/2013, 5/24/2014 and 5/24/2015.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23